Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist

Autor: Ludwig, Barbara, Rotem, Avi, Schmid, Janine, Weir, Gordon C., Colton, Clark K., Brendel, Mathias D., Neufeld, Tova, Block, Norman L., Yavriyants, Karina, Steffen, Anja, Ludwig, Stefan, Chavakis, Triantafyllos, Reichel, Andreas, Azarov, Dimitri, Zimermann, Baruch, Maimon, Shiri, Balyura, Mariya, Rozenshtein, Tania, Shabtay, Noa, Vardi, Pnina, Bloch, Konstantin, de Vos, Paul, Schally, Andrew V., Bornstein, Stefan R., Barkai, Uriel

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2012 Mar . 109(13), 5022-5027.

Externí odkaz: https://www.jstor.org/stable/41588414

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term viability and function of transplanted islets macroencapsulated at high density are achieved by enhanced oxygen supply.

Autor: Evron Y; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Colton CK; Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA. ckcolton@mit.edu., Ludwig B; University Hospital Carl Gustav Carus, Department of Medicine III, 74 Fetscher Street, Dresden, D-01307, Germany., Weir GC; Section of Islet Transplantation and Cell Biology, Joslin Diabetes Center, Research Division, One Joslin Place, Boston, MA, 02215, USA., Zimermann B; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Maimon S; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Neufeld T; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Shalev N; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Goldman T; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Leon A; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Yavriyants K; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Shabtay N; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Rozenshtein T; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Azarov D; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., DiIenno AR; Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA., Steffen A; University Hospital Carl Gustav Carus, Department of Medicine III, 74 Fetscher Street, Dresden, D-01307, Germany., de Vos P; Department of Pathology and Laboratory Medicine, Section of Immunoendocrinology, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands., Bornstein SR; University Hospital Carl Gustav Carus, Department of Medicine III, 74 Fetscher Street, Dresden, D-01307, Germany., Barkai U; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel., Rotem A; Beta-O2 Technologies, Ltd., 11 Amal Street, P.O. Box 11793, Rosh-Ha'ain, 4809900, Israel.

Publikováno v: Scientific reports [Sci Rep] 2018 Apr 25; Vol. 8 (1), pp. 6508. Date of Electronic Publication: 2018 Apr 25.